These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 15454253

  • 1. Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group.
    Cacciavillano WD, Brugières L, Childs M, Shafford E, Brock P, Pritchard J, Mailbach R, Scopinaro M, Perilongo G.
    Eur J Cancer; 2004 Oct; 40(15):2274-9. PubMed ID: 15454253
    [Abstract] [Full Text] [Related]

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Oct; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G.
    J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943
    [Abstract] [Full Text] [Related]

  • 4. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A.
    Cancer; 2002 Feb 15; 94(4):1111-20. PubMed ID: 11920482
    [Abstract] [Full Text] [Related]

  • 5. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP.
    J Clin Oncol; 2006 Jun 20; 24(18):2879-84. PubMed ID: 16782927
    [Abstract] [Full Text] [Related]

  • 6. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 7. The 2000 Burkitt lymphoma trial in Malawi.
    Hesseling P, Broadhead R, Mansvelt E, Louw M, Wessels G, Borgstein E, Schneider J, Molyneux E.
    Pediatr Blood Cancer; 2005 Mar 01; 44(3):245-50. PubMed ID: 15547922
    [Abstract] [Full Text] [Related]

  • 8. Carboplatin and doxorubicin (CARDOX) for nonmetastatic hepatoblastoma: a discouraging pilot study.
    Dall'Igna P, Cecchetto G, Dominici C, Donfrancesco A, Carli M, Indolfi P, Guglielmi M, Perilongo G.
    Med Pediatr Oncol; 2001 Feb 01; 36(2):332-4. PubMed ID: 11452948
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
    Pan C, Tang JY, Chen J, Xue HL, Dong L, Zhou M, Jiang H, Ye QD, Gu LJ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug 01; 11(8):659-62. PubMed ID: 19695195
    [Abstract] [Full Text] [Related]

  • 10. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, Childs M, Pariente D, Laithier V, Otte JB, Branchereau S, Aronson D, Rangaswami A, Ronghe M, Casanova M, Sullivan M, Morland B, Czauderna P, Perilongo G, International Childhood Liver Tumours Strategy Group (SIOPEL).
    Lancet Oncol; 2013 Aug 01; 14(9):834-42. PubMed ID: 23831416
    [Abstract] [Full Text] [Related]

  • 11. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH, Cheung IY, Kramer K, Modak S, Cheung NK.
    Pediatr Blood Cancer; 2007 Apr 01; 48(4):430-4. PubMed ID: 16421906
    [Abstract] [Full Text] [Related]

  • 12. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma.
    Blouin P, Brugières L, Tabone MD, Leverger G, Rubie H, Branchereau S, De Kraker J.
    Pediatr Blood Cancer; 2004 Feb 01; 42(2):149-54. PubMed ID: 14752879
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue.
    Kobrinsky NL, Sjolander DE, Goldenberg JA, Ortmeier TC.
    Pediatr Blood Cancer; 2005 Aug 01; 45(2):222-5. PubMed ID: 15770640
    [Abstract] [Full Text] [Related]

  • 14. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.
    Perilongo G, Shafford E, Maibach R, Aronson D, Brugières L, Brock P, Childs M, Czauderna P, MacKinlay G, Otte JB, Pritchard J, Rondelli R, Scopinaro M, Staalman C, Plaschkes J, International Society of Paediatric Oncology-SIOPEL 2.
    Eur J Cancer; 2004 Feb 01; 40(3):411-21. PubMed ID: 14746860
    [Abstract] [Full Text] [Related]

  • 15. Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.
    Héry G, Franchi-Abella S, Habes D, Brugières L, Martelli H, Fabre M, Pariente D, Gauthier F, Jacquemin E, Branchereau S.
    Pediatr Blood Cancer; 2011 Dec 15; 57(7):1270-5. PubMed ID: 21910210
    [Abstract] [Full Text] [Related]

  • 16. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
    Casanova M, Massimino M, Ferrari A, Spreafico F, Piva L, Coppa J, Luksch R, Cefalo G, Terenziani M, Polastri D, Bellani FF, Mazzaferro V.
    Pediatr Hematol Oncol; 2005 Dec 15; 22(3):189-98. PubMed ID: 16020101
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
    Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, de Camargo B, Zsiros J, Roebuck D, Zimmermann A, Aronson D, Childs M, Widing E, Laithier V, Plaschkes J, Pritchard J, Scopinaro M, MacKinlay G, Czauderna P.
    N Engl J Med; 2009 Oct 22; 361(17):1662-70. PubMed ID: 19846851
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
    Zsíros J, Brugières L, Brock P, Roebuck D, Maibach R, Child M, Morland B, Casanova M, Pariente D, Paris C, de Camargo B, Ronghe M, Zimmermann A, Plaschkes J, Czauderna P, Perilongo G.
    Eur J Cancer; 2012 Dec 22; 48(18):3456-64. PubMed ID: 22835780
    [Abstract] [Full Text] [Related]

  • 19. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
    Li JP, Chu JP, Yang JY, Chen W, Wang Y, Huang YH.
    Cardiovasc Intervent Radiol; 2008 Dec 22; 31(6):1117-23. PubMed ID: 18560935
    [Abstract] [Full Text] [Related]

  • 20. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
    Bernbeck B, Bahci S, Meisel R, Troeger A, Schönberger S, Laws HJ, Kramm C, Wessalowski R, Koscielniak E, Dilloo D, Göbel U.
    Klin Padiatr; 2007 Dec 22; 219(6):318-22. PubMed ID: 18050041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.